MedTrace Logo

Predicting Osteoarthritis Risk Following Knee Injury.

NCT02667756 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2018-05-03

No results posted yet for this study

Summary

This observational study seeks to identify and validate novel soluble biomarkers (within blood, synovial fluid, urine) which contribute to the prognostic assessment of an individual with an acute knee injury, a group of individuals in which \~50% will progress to symptomatic radiographic knee osteoarthritis (OA).

150 individuals will be followed over 5 years with clinical assessment including validated questionnaires, biological sampling and radiological imaging (X ray, magnetic resonance imaging (MRI)).

Conditions

Interventions

OTHER

Non-interventional

Sponsors & Collaborators

  • Imperial College Healthcare NHS Trust

    collaborator OTHER

  • Fortius Clinic

    collaborator OTHER

  • BUPA Cromwell Hospital, London, UK

    collaborator UNKNOWN

  • University of Oxford

    lead OTHER

Principal Investigators

  • Fiona Watt, MD, PhD · University of Oxford

Eligibility

Min Age
16 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02667756 on ClinicalTrials.gov